Loader

Pathways

PathWhiz ID Pathway Meta Data

PW122570

Pw122570 View Pathway
metabolic

Biosynthesis of Siderophore Group Nonribosomal Peptides

Pseudomonas aeruginosa
2,3-Dihydroxybenzoate is synthesized from chorismate via isochorismate and 2,3-dihydroxy-2,3-dihydrobenzoate. The biosynthesis of 2,3-dihydroxybenzoate starts from chorismate being synthesized into isochorismate through isochorismate synthase entC. The N-terminal isochorismate lyase domain of EntB hydrolyzes the pyruvate group of isochorismate to produce 2,3-dihydro-2,3-dihydroxybenzoate. The conversion of this latter compound to 2,3-dihydroxybenzoate is catalyzed by the EntA dehydrogenase. This compound then interacts with L-serine and ATP through the enterobactin synthase protein complex resulting in the production of enterobactin. Enterobactin is exported into the periplasmic space through the enterobactin exporter entS. Enterobactin is then exported into the environment through the outer membrane protein TolC. In the environment, enterobactin reacts with iron to produce ferric enterobactin. It is then imported into the periplasmic space through a ferric enterobactin outer membrane transport complex. Ferric enterobactin continues it's journey and enters the cytoplasm via a ferric enterobactin ABC transporter. Once inside the cytoplasm, ferric enterobactin spontaneously releases the iron ion from the enterobactin. Alternatively, it can react with water through an enterochelin esterase resulting in the release of 2,3-dihydroxybenzoylserine, Fe3+, and hydrogen ions.

PW122264

Pw122264 View Pathway
metabolic

Biosynthesis of type II polyketide backbone

Bacteria
Polyketide synthases (PKSs) are large (Mr 100- to 10,000-kDa) multienzyme systems that are responsible for the stepwise biosynthesis of extraordinarily complex natural products from simple 2-, 3-, and 4-carbon building blocks such as acetyl-CoA, propionyl-CoA, butyryl-CoA, and their activated derivatives, malonyl-, methylmalonyl-, and ethylmalonyl-CoA. These polyketide natural products are known to possess a wealth of pharmacologically important activities, including antimicrobial, antifungal, antiparasitic, antitumor, and immunosuppressive properties.

PW124142

Pw124142 View Pathway
metabolic

Biosynthesis of type II polyketide backbone

Paenibacillus peoriae IBSD35
Polyketide synthases (PKSs) are large (Mr 100- to 10,000-kDa) multienzyme systems that are responsible for the stepwise biosynthesis of extraordinarily complex natural products from simple 2-, 3-, and 4-carbon building blocks such as acetyl-CoA, propionyl-CoA, butyryl-CoA, and their activated derivatives, malonyl-, methylmalonyl-, and ethylmalonyl-CoA. These polyketide natural products are known to possess a wealth of pharmacologically important activities, including antimicrobial, antifungal, antiparasitic, antitumor, and immunosuppressive properties.

PW127014

Pw127014 View Pathway
metabolic

Biosynthesis of type II polyketide backbone 1655806275

Bacteria

PW127015

Pw127015 View Pathway
metabolic

Biosynthesis of type II polyketide backbone 1655806835

Bacteria

PW127016

Pw127016 View Pathway
metabolic

Biosynthesis of type II polyketide backbone 1655806835

Paenibacillus peoriae IBSD35

PW123902

Pw123902 View Pathway
metabolic

Biosynthesis of Type II Polyketide Products

Streptomyces glaucescens
Polyketides are a large group of bioactive secondary metabolites with various biological activities that arise from the diversity in its structures from the precursors of alternating groups like carbonyl and methylene. For this reason, they have a high value in pharmaceutical properties. They are primarily divided into three types: type I, type II and type III polyketides. This pathway focuses on the biosynthesis of type II polyketide products (from the biosynthesis of type II polyketide backbone) which are often based on aromatic molecules produced iteratively by the action of dissociated enzymes in the bacterial species Streptomyces glaucescens. This pathway shows the production of tetracenomycin C and 8-demethyl-tetracenomycin starting from 9,14-decaketides by the action of tcmI, tcmH, tcmN, tcmP, tcmG and tcmO gene proteins. Via a series of reactions using polyketide-synthase, hydroxylase and other enzymes shown in this illustration, the formation of tetracenomycin C occurs. It must be noted that 8-demethyl-tetracenomycin is a derivative of tetracenomycin-C (both shown to be stemming from tetracenomycin-B3) and acts as a teracenomycin having the similar bacterial metabolite role as tetracenomycin-C.

PW002403

Pw002403 View Pathway
metabolic

Biosynthesis of Unsaturated Fatty Acids

Saccharomyces cerevisiae
The biosynthesis of unsaturated fatty acids begins with palmitic acid interacting with ATP and Coenzyme A through an acyl-CoA synthetase resulting in the release of AMP, diphosphate and palmitoyl-CoA. This compound then enters the cycle of unsaturated fatty acid elongation This cycle starts with the acyl-CoA reacting with a hydrogen ion and a malonyl-CoA through a 3-oxo-stearoyl-CoA synthase resulting in the release of a coenzyme A, a carbon dioxide molecule and a 3-oxoacyl-CoA. The 3-oxoacyl-CoA then reacts with a hydrogen ion and an NADPH through a 3-oxoacyl-CoA reductase resulting in the release of an NADP and a (3R)-3-hydroxy-acyl-CoA. The resulting compound then reacts with a trans-2-enoyl-CoA hydratase 2 resulting in the release of water and trans-2,3-dehydroacyl-CoA. This compound then reacts with a hydrogen ion and an NADPH through an enoyl-CoA reductase resulting in the release of a NADP and a new acyl-CoA. The cycle goes from palmitoyl-CoA-->stearoyl-CoA-->eicosanoyl-CoA-->docosanoyl-CoA-->tetracosanoyl-CoA-->hexacosanoyl-CoA. The long-chain fatty acids are then incorporated into the sphingolipid pathway. The long-chain fatty acid reacts with a phytosphingosine through a ceramide synthase resulting in the release of a hydrogen ion, a coenzyme A, and an N-acyl-phytosphinganine.

PW002408

Pw002408 View Pathway
metabolic

Biosynthesis of Unsaturated Fatty Acids (Docosanoyl-CoA)

Saccharomyces cerevisiae
The biosynthesis of unsaturated fatty acids begins with palmitic acid interacting with ATP and Coenzyme A through an acyl-CoA synthetase resulting in the release of AMP, diphosphate and palmitoyl-CoA. This compound then enters the cycle of unsaturated fatty acid elongation This cycle starts with the acyl-CoA reacting with a hydrogen ion and a malonyl-CoA through a 3-oxo-stearoyl-CoA synthase resulting in the release of a coenzyme A, a carbon dioxide molecule and a 3-oxoacyl-CoA. The 3-oxoacyl-CoA then reacts with a hydrogen ion and an NADPH through a 3-oxoacyl-CoA reductase resulting in the release of an NADP and a (3R)-3-hydroxy-acyl-CoA. The resulting compound then reacts with a trans-2-enoyl-CoA hydratase 2 resulting in the release of water and trans-2,3-dehydroacyl-CoA. This compound then reacts with a hydrogen ion and a NADPH through a enoyl-CoA reductase resulting in the release of a NADP and a new acyl-CoA. The cycle goes from palmitoyl-CoA-->stearoyl-CoA-->eicosanoyl-CoA-->docosanoyl-CoA-->tetracosanoyl-CoA-->hexacosanoyl-CoA. The long chain fatty acids are then incorporated into the sphingolipid pathway. The long chain fatty acid reacts with a phytosphingosine through a ceramide synthase resulting in the release of a hydrogen ion, a coenzyme A and a N-acyl-phytosphinganine.

PW002434

Pw002434 View Pathway
metabolic

Biosynthesis of Unsaturated Fatty Acids (Icosanoyl-CoA)

Saccharomyces cerevisiae
The biosynthesis of unsaturated fatty acids begins with palmitic acid interacting with ATP and Coenzyme A through an acyl-CoA synthetase resulting in the release of AMP, diphosphate and palmitoyl-CoA. This compound then enters the cycle of unsaturated fatty acid elongation This cycle starts with the acyl-CoA reacting with a hydrogen ion and a malonyl-CoA through a 3-oxo-stearoyl-CoA synthase resulting in the release of a coenzyme A, a carbon dioxide molecule and a 3-oxoacyl-CoA. The 3-oxoacyl-CoA then reacts with a hydrogen ion and an NADPH through a 3-oxoacyl-CoA reductase resulting in the release of an NADP and a (3R)-3-hydroxy-acyl-CoA. The resulting compound then reacts with a trans-2-enoyl-CoA hydratase 2 resulting in the release of water and trans-2,3-dehydroacyl-CoA. This compound then reacts with a hydrogen ion and a NADPH through a enoyl-CoA reductase resulting in the release of a NADP and a new acyl-CoA. The cycle goes from palmitoyl-CoA-->stearoyl-CoA-->eicosanoyl-CoA-->docosanoyl-CoA-->tetracosanoyl-CoA-->hexacosanoyl-CoA. The long chain fatty acids are then incorporated into the sphingolipid pathway. The long chain fatty acid reacts with a phytosphingosine through a ceramide synthase resulting in the release of a hydrogen ion, a coenzyme A and a N-acyl-phytosphinganine.